A61K 38/1816
Erythropoietin [epo]
Official title: {Erythropoietin [EPO]}
A61K38/1816 (Erythropoietin [epo]) appears on 658 US grants and 1,099 published applications in this corpus.
Search patents in A61K- Granted patents
- 658
- Published applications
- 1,099
- Assignees
- 369
- Inventors
- 1,395
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 3 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 7 | 0 |
| 1998 | 7 | 0 |
| 1999 | 11 | 0 |
| 2000 | 8 | 0 |
| 2001 | 17 | 8 |
| 2002 | 11 | 27 |
| 2003 | 19 | 38 |
| 2004 | 11 | 42 |
| 2005 | 11 | 46 |
| 2006 | 10 | 36 |
| 2007 | 14 | 42 |
| 2008 | 22 | 34 |
| 2009 | 9 | 36 |
| 2010 | 25 | 63 |
| 2011 | 24 | 46 |
| 2012 | 29 | 55 |
| 2013 | 18 | 59 |
| 2014 | 36 | 83 |
| 2015 | 45 | 64 |
| 2016 | 43 | 80 |
| 2017 | 39 | 51 |
| 2018 | 38 | 45 |
| 2019 | 48 | 43 |
| 2020 | 33 | 37 |
| 2021 | 21 | 40 |
| 2022 | 27 | 34 |
| 2023 | 22 | 30 |
| 2024 | 14 | 32 |
| 2025 | 17 | 14 |
| 2026 | 7 | 14 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods of administering chimeric antigen receptor immunotherapy25 Aug 2026US 12,715,925 B2Kite Pharma, Inc.
- Methods of administering chimeric antigen receptor immunotherapy18 Aug 2026US 12,709,639 B2Kite Pharma, Inc.
- Methods of treating anemia using formoterol or a pharmaceutically acceptable salt thereof4 Aug 2026US 12,697,313 B2Dana-Farber Cancer Institute, Inc.
- RNA preparations comprising purified modified RNA for reprogramming cells16 Jun 2026US 12,655,395 B2
- Compositions and methods for treating anemia10 Mar 2026US 12,569,474 B2Akebia Therapeutics, Inc.
- Rna preparations comprising purified modified rna for reprogramming cells1 Oct 2026US 2026/0297538 A1The Trustees of the University of Pennsylvania
- Sevuparin for the treatment of chronic kidney disease30 Jul 2026US 2026/0216232 A1Modus Therapeutics AB
- Erythropoietin and fibronectin compositions for bone regneration9 Jul 2026US 2026/0191932 A1Remedor Biomed Ltd.
- In vivo production of proteins25 Jun 2026US 2026/0174909 A1ModernaTX, Inc.
- Methods of treatment11 Jun 2026US 2026/0158048 A1
Most cited
By later US patents
- RNA containing modified nucleosides and methods of use thereof353US 8,278,036 B2The Trustees of the University of Pennsylvania · 2012
- Oral compositions of proteinaceous medicaments303US 5,206,219 AApplied Analytical Industries, Inc. · 1993
- RNA containing modified nucleosides and methods of use thereof230US 8,691,966 B2The Trustees of the University of Pennsylvania · 2014
- RNA containing modified nucleosides and methods of use thereof222US 8,748,089 B2The Trustees of the University of Pennsylvania · 2014
- RNA containing modified nucleosides and methods of use thereof198US 8,835,108 B2The Trustees of the University of Pennsylvania · 2014